The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population

por Kato, Motokazu, Tomii, Keisuke, Hashimoto, Kenichi, Nezu, Yasuko, Ishii, Takeo, Jones, C Elaine, Kilbride, Sally, Gross, Annette S, Clifton, Christine S, Lipson, David A
Publicado 2019

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

por Marín, José M., Mateos, Luis, Roldán, Juan, Echave-Sustaeta, José M., Pascual-Guardia, Sergi, Pardo, Maria V., Velasco, Beatriz, Jones, C. Elaine, Kilbride, Sally, Lipson, David A.
Publicado 2020

The effect of exacerbation history on outcomes in the IMPACT trial

por Halpin, David M.G., Dransfield, Mark T., Han, MeiLan K., Jones, C. Elaine, Kilbride, Sally, Lange, Peter, Lipson, David A., Lomas, David A., Martinez, Fernando J., Pascoe, Steve, Singh, Dave, Wise, Robert, Criner, Gerard J.
Publicado 2020

The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial

por Han, MeiLan K., Criner, Gerard J., Dransfield, Mark T., Halpin, David M. G., Jones, C. Elaine, Kilbride, Sally, Lange, Peter, Lettis, Sally, Lipson, David A., Lomas, David A., Martin, Neil, Wise, Robert A., Singh, Dave, Martinez, Fernando J.
Publicado 2020

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

por Tabberer, Maggie, Jones, C. Elaine, Kilbride, Sally, Halpin, David M. G., Lomas, David A., Pascoe, Steven, Singh, Dave, Wise, Robert A., Criner, Gerard J., Lange, Peter, Dransfield, Mark T., Han, MeiLan K., Martinez, Fernando J., Kaisermann, Morrys C., Lipson, David A.
Publicado 2020

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardio...

por Day, Nicola C., Kumar, Subramanya, Criner, Gerard, Dransfield, Mark, Halpin, David M. G., Han, MeiLan K., Jones, C. Elaine, Kaisermann, Morrys C., Kilbride, Sally, Lange, Peter, Lomas, David A., Martin, Neil, Martinez, Fernando J., Singh, Dave, Wise, Robert, Lipson, David A.
Publicado 2020

Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial

por Halpin, David M. G., Criner, Gerard J., Dransfield, Mark T., Han, MeiLan K., Hartley, Benjamin, Harvey, Catherine, Jones, C. Elaine, Kato, Motokazu, Lange, Peter, Lettis, Sally, Lomas, David A., Martinez, Fernando J., Martin, Neil, Singh, Dave, Wise, Robert, Zheng, Jinping, Lipson, David A.
Publicado 2020

Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT

por Dransfield, Mark T., Crim, Courtney, Criner, Gerard J., Day, Nicola C., Halpin, David M. G., Han, MeiLan K., Jones, C. Elaine, Kilbride, Sally, LaFon, David, Lipson, David A., Lomas, David A., Martin, Neil, Martinez, Fernando J., Singh, Dave, Wise, Robert A., Lange, Peter
Publicado 2021

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

por Lipson, David A., Crim, Courtney, Criner, Gerard J., Day, Nicola C., Dransfield, Mark T., Halpin, David M. G., Han, MeiLan K., Jones, C. Elaine, Kilbride, Sally, Lange, Peter, Lomas, David A., Lettis, Sally, Manchester, Pamela, Martin, Neil, Midwinter, Dawn, Morris, Andrea, Pascoe, Steven J., Singh, Dave, Wise, Robert A.
Publicado 2020